Stephens Inc’s 89bio ETNB Stock Holding History

Stephens Inc’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,360	Closed	-$291K	–	1238
2023 Q2	$291K	Sell	15,360 -11,014	-42%	-$193K	0.01%	928
2023 Q1	$402K	Sell	26,374 -16,846	-39%	-$220K	0.01%	780
2022 Q4	$550K	Buy	+43,220	New	+$389K	0.01%	663

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Stephens Inc's ETNB Position: Q3 2023 in Review

Stephens Inc sold out of 89bio (ETNB) in Q3 2023, closing a stake of 15,360 shares — an estimated $291K sold.

Stephens Inc first reported a position in ETNB in Q4 2022 and held it in 3 quarters. The position peaked at $550K in Q4 2022. 160 funds tracked by Wall St. Rank hold ETNB as of Q3 2023.

Stephens Inc reported no remaining 89bio position as of Q3 2023 after selling out during the quarter.
Stephens Inc sold 15,360 89bio shares in Q3 2023, an estimated $291K.
Stephens Inc first reported a position in 89bio in Q4 2022 and held it in 3 quarters.
Stephens Inc's 89bio position peaked at $550K in Q4 2022.
160 funds tracked by Wall St. Rank held 89bio as of Q3 2023.

Based on Stephens Inc's 13F filing for Q3 2023, filed 14 Nov 2023.